| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.86B | 37.07B | 37.64B | 39.86B | 37.21B | 28.81B |
| Gross Profit | 13.29B | 13.92B | 13.69B | 13.72B | 12.97B | 10.72B |
| EBITDA | 12.50B | 25.46B | 22.57B | 22.04B | 21.90B | 17.67B |
| Net Income | 5.26B | 6.35B | 6.36B | 5.11B | 7.42B | 4.98B |
Balance Sheet | ||||||
| Total Assets | 262.51B | 257.11B | 229.26B | 222.90B | 189.31B | 174.63B |
| Cash, Cash Equivalents and Short-Term Investments | 2.07B | 3.48B | 5.62B | 20.94B | 4.61B | 5.89B |
| Total Debt | 146.01B | 125.44B | 100.19B | 105.77B | 89.34B | 80.34B |
| Total Liabilities | 172.94B | 171.00B | 146.93B | 142.82B | 116.59B | 107.76B |
| Stockholders Equity | 75.91B | 73.21B | 70.92B | 68.81B | 63.34B | 58.10B |
Cash Flow | ||||||
| Free Cash Flow | -6.98B | -9.80B | -7.32B | 7.35B | -961.59M | -7.40B |
| Operating Cash Flow | 15.88B | 17.06B | 13.88B | 29.61B | 16.76B | 12.27B |
| Investing Cash Flow | -28.63B | -26.07B | -21.43B | -19.01B | -18.47B | -19.44B |
| Financing Cash Flow | 3.48B | 7.35B | -6.26B | 3.84B | 94.54M | 9.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$3.59B | 16.03 | 1.68% | ― | ― | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$10.31B | 8.45 | ― | 4.83% | 3.06% | 6.04% | |
63 Neutral | HK$18.39B | 5.71 | 8.35% | 6.71% | 2.90% | 1.23% | |
60 Neutral | HK$11.13B | 8.62 | 6.83% | 6.26% | 2.47% | -6.46% | |
56 Neutral | HK$116.51B | 15.60 | 7.04% | 5.33% | -9.28% | -7.71% | |
50 Neutral | HK$1.62B | -0.39 | -35.49% | ― | 39.42% | 56.89% |